Coeptis Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell COEP and other ETFs, options, and stocks.

About COEP

Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company, which engages in developing innovative cell therapy platforms for cancer that can disrupt conventional treatment paradigms and improve patient outcomes. It operates through the Biotechnology and Technology segments. 

CEO
David Mehalick
CEODavid Mehalick
Employees
7
Employees7
Headquarters
Wexford, Pennsylvania
HeadquartersWexford, Pennsylvania
Founded
2017
Founded2017
Employees
7
Employees7

COEP Key Statistics

Market cap
79.52M
Market cap79.52M
Price-Earnings ratio
-3.55
Price-Earnings ratio-3.55
Dividend yield
Dividend yield
Average volume
59.88K
Average volume59.88K
High today
$14.55
High today$14.55
Low today
$13.72
Low today$13.72
Open price
$14.17
Open price$14.17
Volume
52.67K
Volume52.67K
52 Week high
$21.41
52 Week high$21.41
52 Week low
$6.26
52 Week low$6.26

Stock Snapshot

As of today, Coeptis Therapeutics(COEP) shares are valued at $14.00. The company's market cap stands at 79.52M, with a P/E ratio of -3.55.

During the trading session on 2026-01-24, Coeptis Therapeutics(COEP) shares reached a daily high of $14.55 and a low of $13.72. At a current price of $14.00, the stock is +2.0% higher than the low and still -3.8% under the high.

Trading volume for Coeptis Therapeutics(COEP) stock has reached 52.67K, versus its average volume of 59.88K.

The stock's 52-week range extends from a low of $6.26 to a high of $21.41.

The stock's 52-week range extends from a low of $6.26 to a high of $21.41.

People also own

Based on the portfolios of people who own COEP. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.